Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000994877 | SCV001148677 | likely pathogenic | not provided | 2019-08-01 | criteria provided, single submitter | clinical testing | |
Institute of Medical Genetics and Applied Genomics, |
RCV003230613 | SCV003929393 | likely pathogenic | Lamb-Shaffer syndrome | 2023-06-02 | criteria provided, single submitter | clinical testing | |
Pittsburgh Clinical Genomics Laboratory, |
RCV003230613 | SCV005397458 | likely pathogenic | Lamb-Shaffer syndrome | 2023-01-06 | criteria provided, single submitter | clinical testing | This sequence variant is a single nucleotide substitution (C>T) at coding position 1672 of the SOX5 gene that results in an arginine to cysteine amino acid change at residue 558 of the SOX5 protein. The Arg558 residue falls in the HMG domain which plays a critical role in SOX5-mediated transactivation (PMID: 31578471). This is a previously reported variant (ClinVar) that has been observed in an individual with Lamb-Shaffer syndrome (PMID: 33296143). This variant is absent from the gnomAD population database (0 of approximately 250,000 alleles). Multiple bioinformatic tools predict that this arginine to cysteine amino acid change would be damaging, and the Arg558 residue is strongly conserved across the vertebrate species examined. Studies examining the functiol consequence of this variant have not been published, to our knowledge. At this time, we consider this a likely pathogenic variant. ACMG Criteria: PM1, PM2, PP3, PS2 |